Compare Illumina, Inc. (ILMN) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Upwork Inc — how do they compare? Illumina, Inc. trades at $191.6 (market cap $27.94B), while Upwork Inc trades at $9.08 (market cap $1.15B). The key difference: Illumina, Inc. is far larger — about 24.3× Upwork Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | UPWK | |
|---|---|---|
Market Cap | $27.94B | $1.15B |
Sector | Health | Industrials |
52-Week High | $194.33 | $22.11 |
52-Week Low | $91.00 | $7.84 |
Enterprise Value | $29.33B | $952.17M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
UPWK trades at $9.33, up 2.98% today, with a neutral technical signal and mixed earnings history including recent EPS misses. Revenue grew to $787.78M in 2025 with strong profitability margins (net margin 13.81%), but cash flow turned negative. Analyst consensus is a Buy with a $10.67 target, though legal investigations and competitive pressures pose headwinds.
The stock offers value with low P/E (11.19) and EV/EBITDA (5.96), but risks include ongoing fraud probes and gig economy volatility. Upside depends on execution amid AI integration initiatives, while downside is cushioned by solid balance sheet liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
